|Articles|June 28, 2016

DrugDev Launches CRO Program with INC Research

DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research.

DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research. Sponsors will be offered use of DrugDevs Golden Number, used to match and master data from disparate sources, and the new DrugDev patient engagment solution, which enables sites to send information, documents and notifications to patients via SMS.

Read the full release here

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

DrugDev Launches CRO Program with INC Research

Related Content

Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV

Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad

ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced

The CRA of the Future: From Monitoring Activity to Strategic Site Partnership

Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data

Trending on Applied Clinical Trials Online

ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced

ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps

Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV

Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad

Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work